TRIB (Trinity Biotech) Inventories, Finished Goods: $3.61 Mil (As of Dec. 2025)


TRIB Trinity Biotech PLC TRIB
28 GF Score
Price $0.41
GF Value $0.74
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Trinity Biotech Inventories, Finished Goods?

Trinity Biotech TRIB +7.84% 28 Inventories, Finished Goods is $3.61 Mil as of Dec. 2025. GuruFocus rates TRIB with a GF Score™ of 28/100 and a GF Value™ of $0.74 (Possible Value Trap). The stock has 7 warning signs investors should review.

Trinity Biotech's quarterly finished goods declined from Dec. 2024 ($4.35 Mil) to Jun. 2025 ($2.85 Mil) but then increased from Jun. 2025 ($2.85 Mil) to Dec. 2025 ($3.61 Mil).

Trinity Biotech's annual finished goods declined from Dec. 2023 ($5.38 Mil) to Dec. 2024 ($4.35 Mil) and declined from Dec. 2024 ($4.35 Mil) to Dec. 2025 ($3.61 Mil).

Trinity Biotech Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Trinity Biotech's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trinity Biotech Inventories, Finished Goods Chart

Trinity Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.93 6.46 5.38 4.35 3.61

Trinity Biotech Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.38 5.62 4.35 2.85 3.61
TRIB
28GF Score
Trinity Biotech PLC TRIB
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Trinity Biotech Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of $3.61 Mil mean?
Trinity Biotech (TRIB) has a Inventories, Finished Goods of $3.61 Mil as of Dec. 2025. Finished goods are inventory items that are complete and ready to be sold. View historical data on Trinity Biotech and its competitors.
Is Trinity Biotech's Inventories, Finished Goods too high?
Trinity Biotech's current Inventories, Finished Goods is $3.61 Mil. Overall, Trinity Biotech has a GF Score™ of 28/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Trinity Biotech's Inventories, Finished Goods compare to AIDX and NVNO?
Trinity Biotech's Inventories, Finished Goods of $3.61 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Medical Devices & Instruments company?
A good Inventories, Finished Goods depends on the Medical Devices & Instruments industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Trinity Biotech and its competitors. Trinity Biotech's current Inventories, Finished Goods is $3.61 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trinity Biotech stock overvalued right now?
Based on GuruFocus' analysis, Trinity Biotech (TRIB) is currently considered Possible Value Trap. The stock's GF Value™ is $0.74, compared to a current price of $0.41 — trading 45.1% below its estimated fair value. The current Inventories, Finished Goods is $3.61 Mil. Trinity Biotech's overall GF Score™ is 28/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Trinity Biotech (TRIB), the current Inventories, Finished Goods is $3.61 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Trinity Biotech (TRIB) Overvalued in 2026?

Based on GuruFocus' analysis, Trinity Biotech stock appears to be undervalued. The current stock price of $0.41 is trading 45.1% below its estimated GF Value™ of $0.74. GuruFocus considers Trinity Biotech to be Possible Value Trap.

Key valuation signals for TRIB:

  • Inventories, Finished Goods: $3.61 Mil
  • GF Value™: $0.74 vs. price of $0.41 (45.1% below fair value)
  • GF Score™: 28/100 with 7 warning signs

No single metric tells the full story. See the TRIB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Trinity Biotech Business Description

Address IDA Business Park, Bray, County Wicklow, Dublin, IRL, A98 H5C8
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.
28GF Score

Get the complete analysis for TRIB

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.41
Price
$0.74
GF Value